Procalcitonin level-guided treatment reduced antibiotic use in exacerbations of COPD: COMMENTARY

Niewoehner, Dennis E.
May 2007
ACP Journal Club;May/Jun2007, Vol. 146 Issue 3, p57
Academic Journal
The article comments on the identification of bacterial infections as commonly cause acute exacerbations of chronic obstructive pulmonary disease. It was found out that inappropriate antibiotic use causes adverse drug events, and selects for resistant bacteria. The author noted that serum procalcitonin levels differentiate systemic bacterial infections from nonbacterial disorders.


Related Articles

  • Procalcitonin -- Hilfsmittel zur Steuerung antibiotischer Therapien?  // Praxis (16618157);2/12/2014, Vol. 103 Issue 4, p187 

    No abstract available.

  • Consider adding this drug to fight COPD that's severe. Hobbs, Keia; Brown, Dionna; Mounsey, Anne // Journal of Family Practice;Jul2012, Vol. 61 Issue 7, p414 

    Daily use of azithromycin, in conjunction with the usual COPD regimen, has been found to reduce acute exacerbations in patients with moderate to severe disease.

  • Should COPD Guidelines Include Prophylactic Antibiotics to Prevent Exacerbations?  // Pulmonary Reviews;Sep2012, Vol. 17 Issue 8, p12 

    The article reports on a paper on the benefits of antibiotic to patients suffering from chronic obstructive pulmonary disease (COPD) published in the July 27, 2012 issue of the "New England Journal of Medicine." The study focused on the pharmacology and adverse effects of azithromycin. The paper...

  • Itraconazole/rifabutin.  // Reactions Weekly;9/19/2009, Issue 1270, p21 

    The article describes the case of a 73-year-old man who experienced bilateral sequential uveitis during treatment with rifabutin and itraconazole. Particular focus is given to the medical history and dosing regimen of the patient who had chronic obstructive pulmonary disease (COPD). The results...

  • Efficacy and Tolerability of Eight Antimicrobial Regimens in the Outpatient Treatment of Exacerbations of Chronic Obstructive Pulmonary Disease. Minov, Jordan; Karadzinska-Bislimovska, Jovanka; Petrova, Tatjana; Vasilevska, Kristin; Stoleski, Sasho; Mijakoski, Dragan; Risteska-Kuc, Snezhana // Macedonian Journal of Medical Sciences;Sep2014, Vol. 7 Issue 3, p519 

    BACKGROUND: Bacterial infections are considered as the most important cause of exacerbations in patients with chronic obstructive pulmonary disease. AIM: To compare the efficacy and tolerability of eight antibiotics empirically administered for outpatient treatment of exacerbations of COPD....

  • Procalcitonin level-guided treatment reduced antibiotic use in exacerbations of COPD. Stolz, D.; Christ-Crain, M.; Bingisser, R. // ACP Journal Club;May/Jun2007, Vol. 146 Issue 3, p57 

    The article examines the antibiotic treatment of exabercations of obstructive pulmonary disease. At the index exabercation, procalcitonin guidance reduced antibiotic use more than did standard therapy and allowed sustained reduction in antibiotic exposure at up to six months. The secondary...

  • Prophylactic Antibiotic Therapy in Chronic Obstructive Pulmonary Disease. Herath, Samantha C.; Poole, Phillippa // JAMA: Journal of the American Medical Association;6/4/2014, Vol. 311 Issue 21, p2225 

    The article discusses a study that reviewed 7 randomized clinical trials (RCT) on prophylactic antibiotic use in chronic obstructive pulmonary disease (COPD). Topics discussed include the association between macrolide prophylaxis and lower incidence of exacerbations, continuous and pulsed...

  • Perspective: The age of the phage. Matsuzaki, Shigenobu; Uchiyama, Jumpei; Takemura-Uchiyama, Iyo; Daibata, Masanori // Nature;5/1/2014 Supplement, Vol. 509 Issue 7498, pS9 

    The author discusses the recent advancement in bacteriophage therapy which is used for the treatment of bacterial infections. Topics discussed include destruction of bacterial cells by phage viruses, advantages of phage therapy over antibiotics due to its effectiveness against...

  • Ciprofloxacin Dosage and Emergence of Resistance in Human Commensal Bacteria. Fantin, Bruno; Duval, Xavier; Massias, Laurent; Alavoine, Loubna; Chau, Françoise; Retout, Sylvie; Andremont, Antoine; Mentré, France // Journal of Infectious Diseases;8/1/2009, Vol. 200 Issue 3, p390 

    Background. Although optimization of the fluoroquinolone dosage increases the efficacy of this class of drugs against bacterial infections, its impact on the emergence of resistance in commensal bacteria is unknown. Methods. Six different 14-day dosages of oral ciprofloxacin were randomly...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics